GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Repros Therapeutics Inc. (RPRX) [hlAlert]

Rating:
Buy RPRX
down 63.67 %

Repros Therapeutics Inc. (RPRX) rated Buy by BofA/Merrill

Posted on: Tuesday,  Jul 2, 2013  8:25 AM ET by BofA/Merrill

BofA/Merrill rated Buy Repros Therapeutics Inc. (NASDAQ: RPRX) on 07/02/2013, when the stock price was $19.82. Since
then, Repros Therapeutics Inc. has lost 63.67% as of 01/14/2016's recent price of $7.20.
If you would have followed this BofA/Merrill's recommendation on RPRX, you would have lost 63.67% of your investment in 926 days.

Repros Therapeutics Inc. (RPRX) is a development-stage biopharmaceutical company focused on the development of oral small molecule drugs for unmet medical needs. The Company's principal drug, Proellex, is a selective blocker of the progesterone receptor and is being developed for the treatment of uterine fibroids, anemia associated with excessive menstrual bleeding relating to uterine fibroids, or anemia associated with uterine fibroids and endometriosis. The second product candidate, Androxal, is a single isomer of clomiphene citrate and an orally active small molecule compound.

BofA/Merrill
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/2/2013 8:25 AM Buy
None
19.82
as of 12/13/2013
1 Week up  0.82 %
1 Month up  17.59 %
3 Months down  -24.18 %
1 YTD down  -13.31 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy